{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:41:04Z","timestamp":1791013264060,"version":"4.1.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The worldwide increase in pediatric overweight and obesity, in parallel with the global increase in the consumption of sucrose and fructose, is associated with non-alcoholic fatty liver disease (NAFLD). Elevated branched-chain amino acids (BCAAs) are a metabolic feature related to obesity and an early risk factor for insulin resistance and NAFLD. However, few studies have assessed metabolic risk factors and nutritional status in maple syrup urine disease (MSUD) patients under restricted BCAA and high carbohydrate diets.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and results<\/jats:title><jats:p>Herein, we present a pilot report of a 17-year-old boy with classic MSUD with poor diet compliance and high fructose consumption, mainly during early adolescence. At that time, he was overweight and developed features of metabolic syndrome, including persistently elevated liver enzymes and hepatic steatosis. He underwent liver transplantation at the age of 13 years to prevent the risk of progressive cognitive impairment. Two months later, NAFLD relapsed in the graft, despite a better BCAA balance and weight loss. Nevertheless, 6 months after dietary restriction of fructose consumption, NAFLD had sustainably improved.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Childhood overweight and fructose overconsumption are wellestablished driving forces in the development of pediatric NAFLD. However, their role in the early onset and progression of NAFLD in the allograft remains to be established. Furthermore, it is not known whether the dysmetabolic state associated with elevated BCAAs may be contributory. Further studies are required with a cohort of MSUD subjects to validate our findings and to ascertain the possible interaction between a BCAA imbalance and dietary intake in the development of NAFLD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2022.933081","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T14:57:08Z","timestamp":1665413828000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case report: NAFLD and maple syrup urine disease: Is there an interplay between branched-chain amino acids and fructose consumption?"],"prefix":"10.3389","volume":"10","author":[{"given":"Helena","family":"Moreira-Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Augusta","family":"Cipriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. R.","family":"Vizca\u00edno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermelinda","family":"Santos-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmeralda","family":"Gomes-Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ymgme.2020.01.006","article-title":"Branched-chain \u03b1-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes","volume":"129","author":"Strauss","year":"2020","journal-title":"Mol Genet Metab."},{"key":"B2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/TACG.S125962","article-title":"Maple syrup urine disease: mechanisms and management","volume":"10","author":"Blackburn","year":"2017","journal-title":"Appl Clin Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"7490","DOI":"10.3390\/ijms21207490","article-title":"Brain branched-chain amino acids in maple syrup urine disease: implications for neurological disorders","volume":"21","author":"Xu","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/ajcn\/68.1.72","article-title":"molecular model of human branched-chain amino acid metabolism","volume":"68","author":"Suryawan","year":"1998","journal-title":"Am J Clin Nutr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3803\/EnM.2019.34.3.234","article-title":"Recent progress on branched-chain amino acids in obesity, diabetes, and beyond","volume":"34","author":"Siddik","year":"2019","journal-title":"Endocrinol Metab."},{"key":"B6","doi-asserted-by":"publisher","first-page":"101261","DOI":"10.1016\/j.molmet.2021.101261","article-title":"Insulin action, type 2 diabetes, and branched-chain amino acids: a two-way street","volume":"52","author":"White","year":"2021","journal-title":"Mol Metab."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.3390\/nu12113331","article-title":"Nutrient intake and nutritional status in adult patients with inherited metabolic diseases treated with low-protein diets: a review on urea cycle disorders and branched chain organic acidemias","volume":"12","author":"Francini-Pesenti","year":"2020","journal-title":"Nutrients."},{"key":"B8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/hep4.1291","article-title":"Childhood fructoholism and fructoholic liver disease","volume":"3","author":"Ribeiro","year":"2019","journal-title":"Hepatol Commun"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"Fructose and sugar: a major mediator of non-alcoholic fatty liver disease","volume":"68","author":"Jensen","year":"2018","journal-title":"J Hepatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/MPG.0000000000001733","article-title":"ESPGHAN committee on nutrition: sugar in infants, children and adolescents: a position paper of the european society for paediatric gastroenterology, hepatology and nutrition committee on nutrition","volume":"65","author":"Fidler Mis","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.10.013","article-title":"Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease","author":"Luukkonen","year":"2021","journal-title":"J Hepatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e12759","DOI":"10.1111\/ijpo.12759","article-title":"The relationship between excessive dietary fructose consumption and paediatric fatty liver disease","volume":"16","author":"DiStefano","year":"2021","journal-title":"Pediatr Obes."},{"key":"B13","doi-asserted-by":"publisher","first-page":"783393","DOI":"10.3389\/fphar.2021.783393","article-title":"The contribution of dietary fructose to non-alcoholic fatty liver disease","volume":"12","author":"Yu","year":"2021","journal-title":"Front Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s40519-016-0315-3","article-title":"Beverage consumption and paediatric NAFLD","volume":"21","author":"Mosca","year":"2016","journal-title":"Eat Weight Disord."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1515\/jpem-2016-0015","article-title":"Dietary fructose intake in obese children and adolescents: relation to procollagen type III N- terminal peptide (P3NP) and non-alcoholic fatty liver disease","volume":"29","author":"Hamza","year":"2016","journal-title":"J Pediatr Endocrinol Metab."},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-49771-5","volume-title":"Inborn Metabolic Diseases: Diagnosis and Treatment","author":"Saudubray","year":"2016"},{"key":"B17","unstructured":"Maple Syrup Urine Disease,\n            HassanSA\n            GuptaV\n          StatPearls PublishingStatPearls2020"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e12948","DOI":"10.1111\/petr.12948","article-title":"A case of classical maple syrup urine disease that was successfully managed by living donor liver transplantation","volume":"21","author":"Takano","year":"2017","journal-title":"Pediatr Transplant."},{"key":"B19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/jmd2.12095","article-title":"Western Canadian complex pediatric therapies follow-up group pre-school neurocognitive and functional outcomes after liver transplant in children with early onset urea cycle disorders, maple syrup urine disease, and propionic acidemia: an inception cohort matched-comparison study","volume":"52","author":"Joffe","year":"2020","journal-title":"JIMD Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ymgme.2014.05.006","article-title":"Nutrition management guideline for maple syrup urine disease: an evidence- and consensus-based approach","volume":"112","author":"Frazier","year":"2014","journal-title":"Mol Genet Metab."},{"key":"B21","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1017\/S0007114519003064","article-title":"Dietary protein insufficiency: an important consideration in fatty liver disease?","volume":"123","author":"Ampong","year":"2020","journal-title":"Br J Nutr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4438","DOI":"10.3390\/nu13124438","article-title":"Dietary composition and its association with newly diagnosed nonalcoholic fatty liver disease and insulin resistance","volume":"13","author":"Charatcharoenwitthaya","year":"2021","journal-title":"Nutrients."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.11.026","article-title":"Systematic review and meta-analysis: the role of diet in the development of nonalcoholic fatty liver disease","author":"Tsompanaki","year":"2021","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1002\/hep4.1915","article-title":"Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: data from the united states scientific registry of transplant recipients","volume":"6","author":"Stepanova","year":"2022","journal-title":"Hepatol Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.07.045","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/liv.14360","article-title":"The role of nutrition in non-alcoholic fatty liver disease: pathophysiology and management","volume":"40","author":"Bern\u00e1","year":"2020","journal-title":"Liver Int."},{"key":"B27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jpeds.2011.06.033","article-title":"Liver transplantation for classical maple syrup urine disease: long-term follow-up in 37 patients and comparative united network for organ sharing experience","volume":"160","author":"Mazariegos","year":"2012","journal-title":"J Pediatr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/lt.25481","article-title":"Maple syrup urine disease and domino liver transplantation: When and how?","volume":"25","author":"Spada","year":"2019","journal-title":"Liver Transpl."},{"key":"B29","doi-asserted-by":"publisher","first-page":"15232","DOI":"10.1038\/s41598-020-72306-x","article-title":"Difference in lifestyle and metabolic profile of non-alcoholic fatty liver disease with raised alanine amino-transferases between obese and non-overweight subjects","volume":"10","author":"Sharma","year":"2020","journal-title":"Sci Rep."},{"key":"B30","first-page":"428","article-title":"Nonalcoholic fatty liver disease after liver transplant","volume":"9","author":"Shetty","year":"2021","journal-title":"J Clin Transl Hepatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"787430","DOI":"10.3389\/fnut.2021.787430","article-title":"Genetic and life style risk factors for recurrent non-alcoholic fatty liver disease following liver transplantation","volume":"8","author":"Iacob","year":"2022","journal-title":"Front Nutr."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1210\/jc.2014-3678","article-title":"Effect of a high-fructose weight-maintaining diet on lipogenesis and liver fat","volume":"100","author":"Schwarz","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/nu14010103","article-title":"Metabolic-associated fatty liver disease (MAFLD), diabetes, and cardiovascular disease: associations with fructose metabolism and gut microbiota","volume":"14","author":"Drozdz","year":"2021","journal-title":"Nutrients."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.jhep.2016.12.025","article-title":"Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents","volume":"66","author":"Mosca","year":"2017","journal-title":"J Hepatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3945\/ajcn.114.086074","article-title":"Higher fructose intake is inversely associated with risk of nonalcoholic fatty liver disease in older Finnish adults","volume":"100","author":"Kanerva","year":"2014","journal-title":"Am J Clin Nutr."},{"key":"B36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/0148607113501201","article-title":"The effect of a low fructose and low glycemic index\/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD)","volume":"39","author":"Mager","year":"2015","journal-title":"JPEN J Parenter Enteral Nutr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12986-018-0271-1","article-title":"Branched-chain amino acids in health and disease: metabolism, alterations in blood plasma, and as supplements","volume":"15","author":"Hole\u010dek","year":"2018","journal-title":"Nutr Metab."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.2337\/db18-0927","article-title":"Targeting BCAA catabolism to treat obesity-associated insulin resistance","volume":"68","author":"Zhou","year":"2019","journal-title":"Diabetes."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1038\/s41366-021-00815-4","article-title":"The effect of physical activity level and exercise training on the association between plasma branched-chain amino acids and intrahepatic lipid content in participants with obesity","volume":"45","author":"Vanweert","year":"2021","journal-title":"Int J Obes."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.933081\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T14:57:12Z","timestamp":1665413832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.933081\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":39,"alternative-id":["10.3389\/fped.2022.933081"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.933081","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,10]]},"article-number":"933081"}}